{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"InMed Pharmaceuticals Inc."},"Symbol":{"label":"Symbol","value":"INM"},"Address":{"label":"Address","value":"815 WEST HASTINGS STREET,SUITE 310, VANCOUVER, British Columbia, V6C 1B4, Canada"},"Phone":{"label":"Phone","value":"+1 604 669-7207"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.inmedpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Eric A. Adams","title":"President, Chief Executive Officer & Director"},{"name":"Michael Woudenberg","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}